These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29441189)

  • 121. Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report.
    Katzell L; Beydler E; Dos Santos AS; Vijayvargiya R; Carr BR
    Front Psychiatry; 2023; 14():1143407. PubMed ID: 37032940
    [TBL] [Abstract][Full Text] [Related]  

  • 122. [Acute catatonic syndrome after neuroleptic malignant syndrome].
    Benjelloun G; Jehel L; Abgrall G; Pelissolo A; Allilaire J
    Encephale; 2005; 31(6 Pt 1):705-9. PubMed ID: 16462690
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases.
    Nisijima K; Ishiguro T
    J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Electroconvulsive Therapy for Parkinson's Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report.
    Mori Y; Miura I; Nozaki M; Osakabe Y; Izumi R; Akama T; Kimura S; Yabe H
    Clin Psychopharmacol Neurosci; 2021 Aug; 19(3):572-575. PubMed ID: 34294629
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Neuroleptic Malignant Syndrome.
    Pileggi DJ; Cook AM
    Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Refractory depression with catatonic features was remitted with administration of intravenous dopamine and consequent bupropion as maintenance treatment.
    Liu YW; Chang C; Chen TY; Chang HA; Kao YC; Tzeng NS
    Aust N Z J Psychiatry; 2016 Jun; 50(6):599. PubMed ID: 26560841
    [No Abstract]   [Full Text] [Related]  

  • 128. Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
    Tse L; Barr AM; Scarapicchia V; Vila-Rodriguez F
    Curr Neuropharmacol; 2015; 13(3):395-406. PubMed ID: 26411967
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.
    Belvederi Murri M; Guaglianone A; Bugliani M; Calcagno P; Respino M; Serafini G; Innamorati M; Pompili M; Amore M
    Drugs R D; 2015 Mar; 15(1):45-62. PubMed ID: 25578944
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports.
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Litta A; Kansky C; Mauri M; Cassano GB; Fagiolini A; Casamassima F
    J Nerv Ment Dis; 2013 Jan; 201(1):36-42. PubMed ID: 23274293
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence.
    Gurrera RJ; Simpson JC; Tsuang MT
    Compr Psychiatry; 2007; 48(2):205-11. PubMed ID: 17292713
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 134. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor.
    Stahl SM; Pradko JF; Haight BR; Modell JG; Rockett CB; Learned-Coughlin S
    Prim Care Companion J Clin Psychiatry; 2004; 6(4):159-166. PubMed ID: 15361919
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Neuroleptic malignant syndrome and catatonia: one entity or two?
    Fink M
    Biol Psychiatry; 1996 Jan; 39(1):1-4. PubMed ID: 8719118
    [No Abstract]   [Full Text] [Related]  

  • 136. Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion.
    Foguet-Boreu Q; Coll-Negre M; Serra-Millàs M; Cavalleria-Verdaguer M
    Clin Pract; 2018 Jan; 8(1):1044. PubMed ID: 29441189
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases.
    Trollor JN; Sachdev PS
    Aust N Z J Psychiatry; 1999 Oct; 33(5):650-9. PubMed ID: 10544988
    [TBL] [Abstract][Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.